v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current Assets    
Cash $ 207,553 $ 173,154
Marketable Securities 3,605,508 8,345,082
Prepaid expenses 1,339,503 893,730
Total Current Assets 5,152,564 9,411,966
Non-Current Assets    
Lease Right-of-Use 10,579
Goodwill 10,498,539 10,498,539
Investment in Oravax Medical 1,500,000 1,500,000
Total Non-Current Assets 11,998,539 12,009,118
Total Assets 17,151,103 21,421,084
Current Liabilities    
Trade and Other Payables 2,677,150 2,902,104
Lease Liability 10,579
Dividends Payable 2,843,017 2,455,675
Derivative Liability 1,303,000
Total Current Liabilities 5,550,149 6,701,340
Total Liabilities 5,550,149 6,701,340
Commitments and Contingencies
Mezzanine Equity    
Total Mezzanine Equity 6,323,667 4,930,004
STOCKHOLDERS’ EQUITY    
Common Stock, par value $0.001, 1,250,000,000 shares authorized, 29,383,743 and 3,363,603 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 29,384 3,364
Additional Paid in Capital 138,952,468 138,780,138
Accumulated Deficit (133,849,089) (129,138,286)
Total Stockholders’ Equity 5,277,287 9,789,740
Total Liabilities and Stockholders’ Equity 17,151,103 21,421,084
Series F Convertible Preferred Stock [Member]    
Mezzanine Equity    
Convertible Preferred Stock, Value 5,130,667 4,930,004
Convertible Preferred Stock – Discount
Convertible Preferred Stock – Derivative
Series F-1 Convertible Preferred Stock [Member]    
Mezzanine Equity    
Convertible Preferred Stock, Value 2,065,426 4,744,101
Convertible Preferred Stock – Discount (2,065,426) (4,744,101)
Series G Convertible Preferred Stock [Member]    
Mezzanine Equity    
Convertible Preferred Stock, Value 8,737,000 8,884,000
Convertible Preferred Stock – Discount (7,544,000) (8,884,000)
Series D Convertible Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred Stock, Value 144,524 144,524
Related Party [Member]    
Current Liabilities    
Due to MyMD FL Shareholders $ 29,982 $ 29,982

Source